EL DORADO HILLS, Calif., March 1, 2007 /PRNewswire-FirstCall via COMTEX/ -- NutraCea (NTRZ , a world leader in stabilized rice bran research and technology, announced today it has entered into an agreement with Giulio Gross, an operating unit of Azelis Italia SpA, with annual sales in 2006 of over $176 M Euros, to distribute NutraCea's proprietary stabilized rice bran products throughout the country of Italy.
"NutraCea's products are very synergistic to our sales in the three divisions of our company, which represent Savoury, General Food and Pharma & Health Food. NutraCea's product line has broad applications, and we pride ourselves in supplying our customers with innovative solutions for their individual needs," said Tonio Grassmann, General Manager of Giulio Gross.
"Giulio Gross has a strong dynamic presence in Italy as the one of the leading distributors for the life sciences industry with a high level of technical sales capability. We are very enthusiastic about the potential of our relationship with this company and their knowledge and skill in working with high caliber companies," said Kody Newland, Senior Vice President of Sales.
"We will be importing our products until NutraCea's initial European plant is operational, which we anticipate will come on line this year," Newland added.
About Giulio Gross
Giulio Gross is a member of Azelis Group and is the Operating Unit of Azelis Italia, with sales over $176M Euros, responsible for the Italian Life Science market, which distributes products for the chemical and Life Science market in Europe. Founded in 1953, Giulio Gross imports and distributes products through three market units. Two units, Savoury and General Food, are responsible for the food industry and offer a wide range of functional ingredients for all food segments; from sausages to cheese, from baked products to various pasty preparations, from gastronomy to frozen food, from ready-to-eat meals to soft drinks. The third market unit is responsible for the Pharma & Health Food industry, offering raw materials and excipients necessary for the production of generic pharmaceutical up to dietetic and nutraceutical products. Giulio Gross is the ideal partner of the food industry, not only for the wide range of technologically advanced products it offers, but also for the accurate and dedicated service and the experienced technical assistance of its staff, aimed at guaranteeing an application service, in respect to current legislation and to total consumer protection.
NutraCea is a world leader in stabilized rice bran technology. Through its wholly owned subsidiary RiceX, the Company manufacturers as well as distributes products and food ingredients made from rice bran through its proprietary technology and processes. The Company has developed intellectual property to create a range of proprietary product formulations, delivery systems and whole food nutrition products. NutraCea's proprietary technology enables the creation of food and nutrition products from rice bran, normally a wasted by-product of standard rice processing. In addition to its whole foods products, NutraCea develops families of health promoting "nutraceuticals," including natural arthritic relief and cholesterol-lowering products. More information can be found in the Company's filings with the SEC and you can visit the NutraCea web site: http://www.NutraCea.com .
This release contains forward-looking statements. Actual results may differ from those projected due to a number of risks and uncertainties, including, but not limited to the possibility that some or all of the pending matters considered by the Company may not proceed as contemplated and the matters specified in the Company's filings with the Securities and Exchange Commission. These statements are made based upon current expectations that are subject to risk and uncertainty. The Company does not undertake to update forward-looking statements in this news release to reflect actual results, changes in assumptions or changes in other factors affecting such forward- looking information. Assumptions and other information that could cause results to differ from those set forth in the forward-looking information can be found in the Company's filings with the Securities and Exchange Commission, including the company's most recent periodic report.